维普中文期刊产品整合服务
133篇 您的检索式:作者名="Andriol GL"
    题名 作者 年代 出处 被引量
1The natural history, skeletal complications, and management of bone metastases in patients with prostate carcinoma显示文摘Carlin BI Andriole GL 2000Cancer2000,88,12:1
2Multilocular cystic nephroma (MLCN) 显示文摘McClexman BL Andriole GL 1989AJR1989,152,6:1
32D versus 3D visual- ization: impact on laparoscopic proficiency using the fundamentals of laparoscopic surgery skill set显示文摘Tanagho YS Andriole GL Paradis AG 2012J Laparoendosc Adv Surg Tech A2012,22,9:1
4Cystotomy,temporary urinary diversion and bladder packing in the management of severe cyclophosphamide-induced hemorrhagic cystitis显示文摘Andriole GL Yuan JJ Catalona WJ 1990J Urol1990,143,5:1
52D versus 3D visualization: impact on laparoseopie proficiency using the fundamentals of laparoscopie surgery skill set 显示文摘Tanagho YS Andriole GL Paradis AG 2012J Laparoendosc Adv Surg Teeh A2012,22,9:1
6Safety and tolerability of the dual 5alpha- reductase inhibitor dutasteride in the treatment of benign prostatichyperplasia显示文摘Andriole GL Kirby R 2003Eur Urol2003,44,1:1
7Benign prostatic hyperplasia : a progressive disease of aging men 显示文摘Emberton M Andriole GL Rosette J 2003Urology2003,61,2:1
82Dversus 3D visualization: impact on laparoscopic proficiency using the fundamentals of laparoscopic surgery skill set 显示文摘Tanagho YS Andriole GL Paradis AG 2012J Laparoen- dosc Adv Surg Tech A2012,22,9:1
92D versus 3D visualization:impact on laparoscopic proficiency using the fudamentals of laparoscopic surgery skill set显示文摘Tanagho YS Andriole GL Paradis AG 2012J Laparoendose Adv Surg Tech A2012,22,9:1
10Safety and tolerability of the dual 5a - reductase inhibitor dutasteride in the treatment of benign prostatic hyperplasia显示文摘Andriol GL Kirby R 2003Eur Urol2003,44,:1
11Anaemia in men receiving combined finasteride and flutamide therapy for advanced prostate cancer显示文摘Ornstein DK Beiser JA Andriole GL 1999BJU Int1999,83,:1
12Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial:mortality results af- ter 13 years of follow-up显示文摘Andriole GL Crawford ED Grubb RL 2012J Natl Cancer Inst2012,104,2:1
13Prostate cancer screening in the randomized prostate,lung,colorectal,and ovarian cancer screening trial:mortality results after 13years of follow-up显示文摘Andriole GL Crawford ED Grubb RL 2012J Nat Cancer Institute2012,104,:1
14Prostate cancer screening in the randomized Prostate,Lung,Colorectal,and Ovarian Cancer Screening Trial:mortality results after 13 years of follow-up显示文摘Andriole GL Crawford ED Grubb RL 3rd 2012J Natl Cancer Inst2012,104,2:1
15Evidence that Iymphokine-activated killer cells and natural killer cells are distinct based on analysis of congenitally immuno-deficient mice显示文摘Andriole GL Mule JJ Hansen CT 1985Immunology1985,135,:1
16The abil-ity of systemic transrectal ultrasound guided biopsy to detect prostate cancer in men with the clinical diagnosis of benign pyostatic hyperplasia显示文摘Coplen DE Andriole GL Yuan JJ Catalona WJ 0,,:1
17Anaemia in men receiving combined finasteride and flutamide therapy for advanced prostate cancer显示文摘Omstein DK Beiser JA Andriole GL 1999BJU Int1999,83,:1
18Benign prostatic hyperplasia: a progressive disease of aging men显示文摘Emberton M Andriole GL de la Rosette J 2003Urology2003,61,2:1
19Effect of dutasteride on the risk of prostate cancer显示文摘ANDRIOLE GL BOSTWICK DG BRAWLEY OW 2010The New England Journal of Medicine2010,362,13:1
20Mortality results from a randomized prostate-cancer screening trial 显示文摘Andriole GL Crawford ED Grubb RL 3rd 2009N Engl J Med2009,360,:1
返回顶部 每页显示:
共7页 首页 上一页 第1页 下一页 末页 /7 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费